Novonesis A/S’s (NVZMY) “Sell” Rating Reaffirmed at Citigroup

Citigroup reaffirmed their sell rating on shares of Novonesis A/S (OTC:NVZMY) in a research report sent to investors on Thursday, StockNewsAPI reports.

Novonesis A/S Stock Down 1.6 %

OTC:NVZMY opened at $65.95 on Thursday. Novonesis A/S has a 12 month low of $38.83 and a 12 month high of $72.50.

About Novonesis A/S

Novonesis A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.